0,872  0,003  GST A substrate
0,858  0,002  Antimutagenic
0,830  0,007  Caspase 9 stimulant
0,821  0,004  CTGF expression inhibitor
0,808  0,003  Sulfotransferase substrate
0,800  0,004  Sensitization
0,801  0,008  TNF expression inhibitor
0,771  0,006  Chemoprotective
0,762  0,004  Free radical scavenger
0,756  0,004  Superoxide dismutase inhibitor
0,757  0,005  Antioxidant
0,752  0,004  Antihypoxic
0,740  0,005  Amyloid beta aggregation inhibitor
0,705  0,005  UGT1A1 substrate
0,694  0,004  UGT1A3 substrate
0,715  0,028  Apoptosis agonist
0,687  0,002  Succinate dehydrogenase inhibitor
0,690  0,010  Radioprotector
0,683  0,005  Antipyretic
0,677  0,002  Cystathionine beta-synthase inhibitor
0,673  0,004  NOS3 expression enhancer
0,668  0,002  GST P1-1 substrate
0,685  0,022  Antineoplastic (breast cancer)
0,673  0,012  Antihypercholesterolemic
0,668  0,011  Aldehyde oxidase inhibitor
0,659  0,007  AR expression inhibitor
0,657  0,006  UGT1A6 substrate
0,674  0,024  Transcription factor NF kappa B inhibitor
0,658  0,016  CYP2C9 substrate
0,652  0,012  Cholesterol antagonist
0,643  0,005  Ulceration
0,647  0,011  Vasodilator, peripheral
0,662  0,038  Antiinflammatory
0,620  0,005  Antiseptic
0,624  0,009  Antipruritic, allergic
0,621  0,006  UDP-glucuronosyltransferase substrate
0,617  0,009  Histamine release inhibitor
0,611  0,009  Lipoxygenase inhibitor
0,603  0,005  Monophenol monooxygenase inhibitor
0,602  0,009  Apoptosis antagonist
0,597  0,006  FMO1 substrate
0,607  0,017  Carcinogenic
0,600  0,012  UGT1A9 substrate
0,585  0,005  Antihypertriglyceridemic
0,582  0,005  Peroxidase inhibitor
0,577  0,003  Carbonic anhydrase VI inhibitor
0,585  0,011  NOS2 expression inhibitor
0,573  0,005  Skin whitener
0,575  0,014  Proliferative diseases treatment
0,567  0,010  Skin irritative effect
0,569  0,016  CYP1A2 substrate
0,562  0,014  Cardiovascular analeptic
0,563  0,015  Chemopreventive
0,548  0,003  Carbonic anhydrase III inhibitor
0,548  0,003  Tyrosine 3 hydroxylase inhibitor
0,576  0,032  Cyclophilin D inhibitor
0,576  0,032  Antidiabetic
0,548  0,005  UGT2B4 substrate
0,543  0,003  GABA C receptor agonist
0,552  0,017  Mutagenic
0,544  0,012  Hypoglycemic
0,533  0,005  Amylase inhibitor
0,529  0,003  HIV-1 integrase (3'-Processing) inhibitor
0,524  0,006  Melanin inhibitor
0,533  0,018  Cardioprotectant
0,543  0,028  Teratogen
0,536  0,024  Antithrombotic
0,541  0,033  Antileukemic
0,509  0,004  Carcinogenic, group 2B
0,528  0,023  CYP2C19 substrate
0,527  0,023  Bone diseases treatment
0,520  0,018  Antiosteoporotic
0,506  0,006  Phospholipase C inhibitor
0,503  0,005  VCAM1 expression inhibitor
0,497  0,004  SULT1A3 substrate
0,506  0,019  NOS3 expression inhibitor
0,486  0,005  Antidote
0,495  0,014  Eye irritation, high
0,483  0,003  Histidine decarboxylase inhibitor
0,484  0,005  Pneumotoxic
0,482  0,006  Platelet adhesion inhibitor
0,502  0,031  Embryotoxic
0,478  0,009  Anesthetic general
0,480  0,016  ICAM1 expression inhibitor
0,469  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,464  0,005  Glutathione S-transferase substrate
0,459  0,003  Phenylalanine 4-hydroxylase inhibitor
0,459  0,003  Prostaglandin EP2 antagonist
0,479  0,025  Antineoplastic (cervical cancer)
0,457  0,003  Keratolytic
0,460  0,007  FMO3 substrate
0,463  0,012  Pyruvate kinase inhibitor
0,466  0,019  Antiamyloidogenic
0,449  0,005  Chelator
0,468  0,025  Caspase 3 stimulant
0,448  0,005  Antipruritic, non-allergic
0,486  0,044  15-Lipoxygenase inhibitor
0,465  0,026  Lipoprotein disorders treatment
0,441  0,005  5-Lipoxygenase inhibitor
0,451  0,019  Platelet antagonist
0,445  0,013  Antiulcerative
0,439  0,008  Lipid peroxidase inhibitor
0,439  0,009  Carcinogenic, group 3
0,465  0,036  Stroke treatment
0,449  0,020  Nitric oxide antagonist
0,458  0,029  Hepatic disorders treatment
0,429  0,004  HIV-1 integrase (Strand Transfer) inhibitor
0,461  0,036  CYP2C19 inhibitor
0,463  0,039  Prostate cancer treatment
0,438  0,018  Radiosensitizer
0,436  0,016  Antineoplastic (osteosarcoma)
0,424  0,005  Insulin sensitizer
0,458  0,039  GABA C receptor rho-3 antagonist
0,454  0,036  Antiallergic
0,452  0,033  CYP2D6 substrate
0,425  0,007  Protein-tyrosine phosphatase inhibitor
0,433  0,020  Antidiabetic symptomatic
0,422  0,009  UGT2B7 substrate
0,422  0,010  Genotoxic
0,442  0,031  Antipsoriatic
0,436  0,026  Antineoplastic (non-small cell lung cancer)
0,430  0,027  Vasodilator, coronary
0,405  0,003  Glutamate decarboxylase inhibitor
0,413  0,012  5 Hydroxytryptamine uptake stimulant
0,402  0,004  Carbonic anhydrase XIII inhibitor
0,412  0,015  Flavin-containing monooxygenase substrate
0,411  0,020  Myocardial infarction treatment
0,413  0,024  Antineoplastic (lymphoma)
0,425  0,039  Antineoplastic (ovarian cancer)
0,412  0,028  Antiprotozoal (Leishmania)
0,398  0,019  Antineoplastic (lymphocytic leukemia)
0,383  0,004  Choleretic
0,395  0,016  UGT1A4 substrate
0,390  0,014  GST M1-1 substrate
0,403  0,028  DNA damaging
0,392  0,017  Abortion inducer
0,396  0,022  Vascular (periferal) disease treatment
0,404  0,030  Interleukin antagonist
0,378  0,006  M18 aspartyl aminopeptidase inhibitor
0,431  0,058  Antineoplastic (lung cancer)
0,379  0,010  Protein kinase stimulant
0,431  0,063  Antibacterial
0,373  0,005  Cholesterol synthesis inhibitor
0,377  0,010  UGT2B15 substrate
0,389  0,025  Vasodilator
0,382  0,022  Interleukin agonist
0,399  0,039  12-Lipoxygenase inhibitor
0,383  0,025  Insulysin inhibitor
0,363  0,007  Antihelmintic (Nematodes)
0,355  0,004  Porphobilinogen synthase inhibitor
0,392  0,046  Respiratory analeptic
0,370  0,026  Transcription factor STAT3 inhibitor
0,385  0,043  Antineoplastic (brain cancer)
0,344  0,003  Heat shock protein 70 antagonist
0,401  0,062  CYP3A4 substrate
0,344  0,007  UGT2B1 substrate
0,354  0,018  Hepatoprotectant
0,341  0,005  Estrogen antagonist
0,342  0,008  Protein-tyrosine phosphatase 1B inhibitor
0,348  0,014  DNA methyltransferase I inhibitor
0,360  0,030  Transcription factor STAT inhibitor
0,337  0,009  Interleukin 1 antagonist
0,330  0,004  SULT1A1 substrate
0,344  0,019  Antihypotensive
0,358  0,034  Hypolipemic
0,332  0,009  DNA polymerase I inhibitor
0,354  0,031  Angiogenesis stimulant
0,362  0,040  CYP1A2 inhibitor
0,326  0,005  Antispirochetal
0,338  0,017  Antiacne
0,329  0,008  UGT2B9 substrate
0,324  0,005  ABCA1 expression enhancer
0,325  0,007  Expectorant
0,397  0,080  5 Hydroxytryptamine release inhibitor
0,365  0,048  Spasmolytic
0,359  0,042  Hypoxia-inducible factor 1 alpha inhibitor
0,350  0,033  Antineoplastic (endocrine cancer)
0,353  0,038  Sodium/bile acid cotransporter inhibitor
0,321  0,006  Xanthine oxidase inhibitor
0,320  0,006  Mediator release inhibitor
0,318  0,004  Macrophage migration inhibitory factor inhibitor
0,358  0,045  Calcium channel activator
0,331  0,020  DNA methylase inhibitor
0,358  0,049  Analeptic
0,326  0,017  Interferon gamma antagonist
0,321  0,013  Neurotrophic factor enhancer
0,324  0,017  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,350  0,044  Antidiabetic (type 2)
0,318  0,012  Corneal wound healing stimulator
0,340  0,038  Antiglaucomic
0,317  0,015  Liver fibrosis treatment
0,306  0,005  Alcohol dehydrogenase substrate
0,315  0,014  CYP2B6 inhibitor
0,373  0,075  Immunosuppressant
0,301  0,004  Alcohol oxidase inhibitor
0,320  0,024  Non-steroidal antiinflammatory agent
0,308  0,012  Phospholipase A2 inhibitor
0,312  0,018  Acaricide
0,345  0,055  Antineoplastic (melanoma)
0,299  0,010  Antifungal enhancer
0,293  0,006  UGT2B10 substrate
0,332  0,045  Cytostatic
0,323  0,037  DNA synthesis inhibitor
0,289  0,006  Mannose-6-phosphate isomerase inhibitor
0,283  0,003  Ornithine decarboxylase inhibitor
0,339  0,059  Antiischemic
0,284  0,004  HIV-1 integrase (Overall Integration) inhibitor
0,289  0,009  Interleukin 1b antagonist
0,289  0,010  Gout treatment
0,281  0,004  Carbonic anhydrase V inhibitor
0,299  0,025  Peptidyltransferase inhibitor
0,277  0,005  NAD(P)H dehydrogenase (quinone) inhibitor
0,281  0,009  Ferrochelatase inhibitor
0,350  0,081  CYP2C9 inhibitor
0,296  0,029  Dual specificity phosphatase 3 inhibitor
0,273  0,007  Catalase inhibitor
0,297  0,032  Antihelmintic
0,285  0,021  Tubulin antagonist
0,385  0,121  Alpha-glucosidase inhibitor
0,293  0,030  P-glycoprotein inhibitor
0,312  0,049  Tumour necrosis factor alpha release inhibitor
0,304  0,042  Antiparasitic
0,273  0,012  Antianemic
0,329  0,068  Antifungal
0,264  0,004  Carbonic anhydrase VB inhibitor
0,264  0,005  Vanilloid 1 agonist
0,271  0,011  Uterine stimulant
0,264  0,005  Antirickettsial
0,308  0,049  Antineoplastic (renal cancer)
0,320  0,061  Interleukin 2 agonist
0,288  0,031  Dual specificity phosphatase inhibitor
0,259  0,004  HIV-1 integrase inhibitor
0,278  0,024  Restenosis treatment
0,272  0,018  Cyclooxygenase 1 inhibitor
0,258  0,004  Glutathione S-transferase inhibitor
0,255  0,003  Prostaglandin EP3 antagonist
0,266  0,015  LDLR expression enhancer
0,275  0,024  Amyloid beta precursor protein antagonist
0,255  0,008  Toll-Like receptor 2 antagonist
0,250  0,004  GABA aminotransferase inhibitor
0,260  0,014  Cell adhesion inhibitor
0,262  0,016  Antihyperlipoproteinemic
0,249  0,004  Adenylate cyclase stimulant
0,249  0,004  Leukotriene antagonist
0,260  0,018  Insulin secretagoues
0,295  0,053  Cardiodepressant
0,247  0,005  Creatine kinase inhibitor
0,309  0,068  Antineoplastic (small cell lung cancer)
0,251  0,010  Antieczematic
0,244  0,004  Carbonic anhydrase VA inhibitor
0,252  0,013  ATPase inhibitor
0,267  0,030  Mcl-1 antagonist
0,244  0,008  Uric acid excretion stimulant
0,290  0,053  Cytotoxic
0,249  0,013  Excitatory amino acid transporter EAAC1 inhibitor
0,240  0,004  DOPA decarboxylase inhibitor
0,240  0,005  Aldose reductase inhibitor
0,289  0,056  Antineoplastic (liver cancer)
0,240  0,008  Arachidonic acid antagonist
0,248  0,019  Adenylate cyclase inhibitor
0,243  0,014  Phobic disorders treatment
0,278  0,051  Gastrin inhibitor
0,277  0,051  Antimitotic
0,254  0,028  Hair growth stimulant
0,244  0,019  Aldehyde dehydrogenase inhibitor
0,255  0,029  Nitric-oxide synthase stimulant
0,228  0,004  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,229  0,005  Prolactin inhibitor
0,229  0,009  Phosphofructokinase-1 inhibitor
0,287  0,068  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,225  0,007  Actinic keratosis treatment
0,222  0,004  Xanthine dehydrogenase inhibitor
0,290  0,073  Antineoplastic (multiple myeloma)
0,221  0,004  Carbonic anhydrase XIV inhibitor
0,228  0,012  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,226  0,010  Beta glucuronidase inhibitor
0,236  0,021  Carcinogenic, group 1
0,223  0,009  Triose-phosphate isomerase inhibitor
0,278  0,065  Antineoplastic (glioma)
0,295  0,083  Antineoplastic (colorectal cancer)
0,219  0,010  Aldehyde dehydrogenase substrate
0,224  0,015  Microtubule formation inhibitor
0,231  0,024  VEGF expression inhibitor
0,214  0,009  Glutamate dehydrogenase inhibitor
0,213  0,008  TRPA1 agonist
0,209  0,004  Transcription factor AP-1 inhibitor
0,219  0,016  Carbonic anhydrase XV inhibitor
0,213  0,012  Dementia treatment
0,254  0,053  Antiviral (HIV)
0,283  0,084  Immunostimulant
0,209  0,012  Vascular dementia treatment
0,224  0,026  Antidiarrheal
0,241  0,046  Antiviral (West Nile virus)
0,226  0,034  MAO inhibitor
0,225  0,032  Cyclooxygenase inhibitor
0,195  0,005  UGT2B11 substrate
0,216  0,027  Antiprotozoal (Coccidial)
0,240  0,051  Antiviral (Influenza)
0,202  0,013  Mucolytic
0,195  0,007  Toll-Like receptor 4 antagonist
0,219  0,032  Aldehyde oxidase substrate
0,191  0,005  NMDA receptor agonist
0,190  0,004  Leukotriene B4 antagonist
0,189  0,003  Aconitate hydratase inhibitor
0,196  0,012  AMP-activated protein kinase stimulant
0,195  0,013  Alcohol dehydrogenase inhibitor
0,235  0,052  Sigma receptor agonist
0,203  0,021  Antihemorrhagic
0,211  0,030  Neurotensin receptor agonist
0,246  0,065  Cyclic AMP phosphodiesterase inhibitor
0,188  0,008  Vanilloid agonist
0,267  0,087  Antineoplastic (colon cancer)
0,312  0,133  Antiparkinsonian
0,194  0,016  Adenylate kinase inhibitor
0,185  0,008  CDC25A inhibitor
0,262  0,086  Antineoplastic (pancreatic cancer)
0,219  0,043  Thrombolytic
0,184  0,009  Estrogen receptor alpha antagonist
0,189  0,015  Antihelmintic (Fasciola)
0,234  0,060  RNA-directed DNA polymerase inhibitor
0,182  0,010  Thioredoxin inhibitor
0,190  0,018  Coagulant
0,209  0,037  Anesthetic
0,179  0,008  Peroxisome proliferator-activated receptor gamma agonist
0,185  0,014  Arylamine N-Acetyltransferase substrate
0,282  0,113  Thioredoxin glutathione reductase inhibitor
0,177  0,008  Prostaglandin antagonist
0,172  0,003  Catechol O-methyltransferase inhibitor
0,177  0,008  Ca2+-transporting ATPase inhibitor
0,312  0,144  Antiarthritic
0,237  0,069  Neuropeptide Y2 antagonist
0,175  0,008  Antifungal (Pneumocystis)
0,197  0,031  Cell wall synthesis inhibitor
0,190  0,025  Interleukin 4 antagonist
0,188  0,023  Cyclooxygenase 3 inhibitor
0,182  0,018  Gastritis treatment
0,252  0,088  5 Hydroxytryptamine release stimulant
0,212  0,050  Muscle relaxant
0,188  0,026  Farnesoid X receptor antagonist
0,173  0,013  NADH dehydrogenase inhibitor
0,168  0,010  Estrogen agonist
0,198  0,041  Skeletal muscle relaxant
0,161  0,004  Antiviral (Parainfluenza)
0,161  0,005  Plasminogen activator inhibitor antagonist
0,160  0,005  Anticholelithogenic
0,198  0,043  Antiviral (Hepatitis C)
0,162  0,008  Biliverdin reductase inhibitor
0,207  0,054  Antiviral (Hepatitis)
0,177  0,025  Growth stimulant
0,190  0,038  Aldose reductase substrate
0,175  0,022  UDP-glucose 4-epimerase inhibitor
0,163  0,011  Beta tubulin antagonist
0,180  0,028  MAO B inhibitor
0,192  0,043  CNS active muscle relaxant
0,171  0,023  Interleukin 8 antagonist
0,159  0,011  Antidote, mercury
0,153  0,005  SULT1A2 substrate
0,155  0,008  Prostaglandin E2 antagonist
0,221  0,074  Antineoplastic (glioblastoma multiforme)
0,212  0,066  Wound healing agent
0,303  0,160  DNA directed DNA polymerase inhibitor
0,149  0,006  CDC25B inhibitor
0,156  0,014  Estrogen receptor beta antagonist
0,145  0,003  Retinoid X alpha receptor agonist
0,161  0,022  Antiviral (Influenza B)
0,187  0,048  Antiparkinsonian, tremor relieving
0,214  0,076  Antiparkinsonian, rigidity relieving
0,150  0,012  Postmenopausal disorders treatment
0,143  0,004  Prostaglandin agonist
0,159  0,022  Caspase 3 inhibitor
0,152  0,015  Cell adhesion molecule inhibitor
0,179  0,043  Alkaline phosphatase inhibitor
0,157  0,022  Breast cancer-resistant protein inhibitor
0,168  0,033  Antiprotozoal (Amoeba)
0,166  0,032  Antineoplastic antimetabolite
0,197  0,063  Antieczematic atopic
0,160  0,027  Contraceptive female
0,136  0,004  Glucose-6-phosphate translocase inhibitor
0,209  0,078  Antineoplastic enhancer
0,167  0,036  Cathepsin H inhibitor
0,167  0,037  Sphingosine 1-phosphate receptor 5 antagonist
0,166  0,035  Antibacterial (Helicobacter pylori)
0,168  0,038  Alkylator
0,133  0,003  Retinoid X receptor agonist
0,146  0,017  SULT1E1 substrate
0,135  0,005  Endocannabinoid uptake inhibitor
0,156  0,028  Papain-like protease (SARS coronavirus) inhibitor
0,164  0,036  Antihelmintic (Trematoda)
0,295  0,168  DNA polymerase beta inhibitor
0,133  0,007  Carbonic anhydrase VII inhibitor
0,176  0,050  Antineoplastic (squamous cell carcinoma)
0,132  0,006  NMDA receptor glycine site agonist
0,145  0,021  Anabolic
0,138  0,014  Phosphodiesterase 6D inhibitor
0,142  0,019  Selectin antagonist
0,164  0,042  Antifungal (Cryptococcus)
0,131  0,009  Phosphorylase inhibitor
0,139  0,017  Antiviral (Rhinovirus)
0,130  0,010  Purinergic P2X1 antagonist
0,124  0,006  GABA B receptor agonist
0,149  0,032  DNA repair enzyme inhibitor
0,148  0,031  GABA C receptor antagonist
0,121  0,004  Retinoic acid alpha receptor agonist
0,139  0,023  GST T1-1 substrate
0,119  0,004  Leukotriene B4 receptor 1 antagonist
0,119  0,004  SULT2A1 substrate
0,129  0,014  Leukotriene synthesis inhibitor
0,168  0,053  Raynaud's phenomenon treatment
0,119  0,004  Retinoic acid receptor agonist
0,148  0,034  Antiviral (Papilloma)
0,116  0,003  Retinoid X beta receptor agonist
0,150  0,038  Aminopeptidase B inhibitor
0,193  0,080  Septic shock treatment
0,145  0,034  Photosensitizer
0,115  0,003  Retinoid X gamma receptor agonist
0,166  0,055  GABA C receptor rho-2 antagonist
0,263  0,152  Atherosclerosis treatment
0,159  0,048  Cyclooxygenase 2 inhibitor
0,120  0,010  Maillard reaction inhibitor
0,169  0,060  Acute respiratory distress syndrome (ARDS) treatment
0,114  0,005  Thromboxane synthase inhibitor
0,119  0,010  Estrogen-related receptor beta agonist
0,177  0,069  Tumour necrosis factor antagonist
0,176  0,068  Antineoplastic (bone cancer)
0,218  0,110  5 Hydroxytryptamine 1E antagonist
0,120  0,013  D-Ala-D-Ala ligase inhibitor
0,121  0,015  Hyperparathyroidism treatment
0,121  0,015  Carbamoyl phosphate synthetase inhibitor
0,109  0,004  Glucose-6-phosphate isomerase inhibitor
0,122  0,018  Bile acid receptor antagonist
0,143  0,039  Sphingosine 1-phosphate receptor 4 antagonist
0,122  0,018  ATPase (Vacuolar H+) inhibitor
0,113  0,010  Peroxisome proliferator-activated receptor alpha agonist
0,106  0,003  Sodium-dependent vitamin C transporter 2 inhibitor
0,120  0,017  Thioredoxin reductase inhibitor
0,119  0,017  Granulocyte macrophage colony stimulating factor agonist
0,147  0,045  Sphingosine 1-phosphate receptor 2 antagonist
0,116  0,014  Glycine receptor agonist
0,105  0,004  Prostaglandin E2 agonist
0,150  0,049  Retinoprotector
0,103  0,003  Kainate receptor agonist
0,188  0,088  Histone acetyltransferase inhibitor
0,133  0,034  Potassium channel (Ca-activated) activator
0,142  0,043  MAO A inhibitor
0,105  0,007  Exportin-1 inhibitor
0,151  0,053  Cocaine dependence treatment
0,162  0,065  Hexokinase inhibitor
0,132  0,035  Gastric antisecretory
0,108  0,011  Antitreponemal
0,129  0,033  GABA C receptor rho-1 antagonist
0,101  0,005  Fumarate hydratase inhibitor
0,106  0,010  Estradiol 17 beta-dehydrogenase inhibitor
0,109  0,014  Alpha tubulin antagonist
0,275  0,180  Calcium channel L-type activator
0,134  0,039  Transcription factor STAT6 inhibitor
0,104  0,010  Thromboxane antagonist
0,231  0,138  Prostaglandin dehydrogenase inhibitor
0,130  0,039  Antineoplastic, alkylator
0,132  0,041  HDL-cholesterol increasing
0,190  0,100  Age-related macular degeneration treatment
0,111  0,023  Na+ K+ transporting ATPase inhibitor
0,090  0,003  Retinoic acid alpha receptor antagonist
0,159  0,071  Antiviral (Herpes)
0,122  0,035  NMDA receptor antagonist
0,092  0,005  Leukotriene C antagonist
0,141  0,054  Topoisomerase II inhibitor
0,091  0,005  Prostaglandin EP4 antagonist
0,149  0,063  Cytokine production inhibitor
0,094  0,009  Heme oxygenase stimulant
0,094  0,009  Thromboxane A2 antagonist
0,089  0,004  LFA antagonist
0,164  0,079  Antipruritic
0,154  0,070  Antiviral (Influenza A)
0,103  0,018  Argininosuccinate synthase inhibitor
0,100  0,016  Peroxisome proliferator-activated receptor gamma antagonist
0,110  0,026  Myeloperoxidase inhibitor
0,100  0,016  Acyl-CoA dehydrogenase inhibitor
0,207  0,123  Antineoplastic (bladder cancer)
0,107  0,024  Aminopeptidase I inhibitor
0,128  0,045  NAT2 substrate
0,112  0,029  Cathepsin G inhibitor
0,091  0,010  Estrogen receptor alpha agonist
0,087  0,006  Factor III inhibitor
0,273  0,192  Alzheimer's disease treatment
0,094  0,014  Prostaglandin F2 alpha antagonist
0,150  0,069  Antineoplastic (carcinoma)
0,088  0,008  Squalene epoxidase inhibitor
0,129  0,049  Shock treatment
0,116  0,037  Antifungal (Aspergillus)
0,111  0,033  Antifungal (Candida)
0,081  0,003  Retinoic acid receptor antagonist
0,082  0,004  GABA transporter 3 inhibitor
0,093  0,015  Antimycoplasmal
0,102  0,024  Sphingosine 1-phosphate receptor 4 agonist
0,143  0,065  Bone formation stimulant
0,103  0,026  NAT1 substrate
0,149  0,073  Antiischemic, cerebral
0,080  0,003  Retinoid X receptor antagonist
0,088  0,012  Glutamate (mGluR group III) agonist
0,081  0,004  Glutamate (mGluR8) agonist
0,116  0,040  Electrolyte absorption antagonist
0,121  0,045  Anticataract
0,082  0,006  Dopamine D5 agonist
0,094  0,018  Antidote, heavy metal
0,080  0,004  Prostaglandin EP2 agonist
0,088  0,013  Botulinum neurotoxin type A inhibitor
0,102  0,027  Histone deacetylase stimulant
0,102  0,027  Histone deacetylase SIRT1 stimulant
0,180  0,107  5 Hydroxytryptamine 3E antagonist
0,080  0,008  Adenylate cyclase 1 inhibitor
0,110  0,038  Paget's disease treatment
0,075  0,003  ICAM 1 antagonist
0,147  0,077  Movement disorders treatment
0,139  0,069  Neurotrophic factor
0,083  0,014  Estrogen receptor beta agonist
0,104  0,036  Metalloproteinase-2 inhibitor
0,086  0,018  Glutamate (mGluR6) antagonist
0,092  0,024  Antidote, organophosphates
0,089  0,021  Protease 3C (Human rhinovirus) inhibitor
0,071  0,004  ATP citrate lysase inhibitor
0,073  0,007  RNA-directed RNA polymerase inhibitor
0,079  0,014  Postcoital contraceptive
0,081  0,016  Transcription factor RelA inhibitor
0,142  0,078  Thiol protease inhibitor
0,107  0,043  Calcium antagonist
0,099  0,035  Antibiotic
0,073  0,010  Heparanase inhibitor
0,066  0,003  Retinoid X alpha receptor antagonist
0,114  0,051  Urease inhibitor
0,075  0,013  Dihydroorotate oxidase inhibitor
0,067  0,005  NMDA 2D receptor antagonist
0,100  0,039  Topoisomerase II alpha inhibitor
0,083  0,023  Neuraminidase inhibitor
0,072  0,012  Pregnane X receptor antagonist
0,065  0,005  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,083  0,023  NMDA 2C receptor antagonist
0,164  0,105  Psychostimulant
0,148  0,089  Growth hormone agonist
0,064  0,005  Leukotriene C4 antagonist
0,097  0,039  Inducible nitric-oxide synthase inhibitor
0,082  0,024  Neuraminidase (influenza) inhibitor
0,062  0,004  Retinoic acid beta receptor agonist
0,102  0,044  Carcinogenic, group 2A
0,071  0,014  Lysophosphatidic acid 3 receptor antagonist
0,154  0,097  Catenin beta inhibitor
0,061  0,004  Leukotriene B4 receptor 2 antagonist
0,093  0,036  Metalloproteinase-9 inhibitor
0,071  0,015  Adenine nucleotide translocase inhibitor
0,066  0,010  Kainate receptor 2 antagonist
0,071  0,016  DNA helicase inhibitor
0,244  0,190  Transcription factor inhibitor
0,058  0,005  Prostaglandin EP4 agonist
0,089  0,035  Narcotic antagonist
0,073  0,020  Glycine transporter 2 inhibitor
0,056  0,003  Retinoic acid gamma receptor agonist
0,085  0,033  MAP kinase kinase 7 inhibitor
0,059  0,007  GABA transporter 2 inhibitor
0,067  0,016  Vanilloid 2 antagonist
0,067  0,017  CD45 antagonist
0,053  0,003  Retinoid X gamma receptor antagonist
0,188  0,138  Antituberculosic
0,106  0,056  Chronic obstructive bronchitis treatment
0,074  0,024  Enoyl-[acyl-carrier-protein] reductase inhibitor
0,059  0,010  Prostacyclin antagonist
0,053  0,004  Thyroid hormone agonist
0,136  0,087  Hemostatic
0,135  0,086  Pregnane X receptor agonist
0,078  0,030  Glutamate (mGluR7) antagonist
0,057  0,009  Leukotriene D4 antagonist
0,059  0,010  Farnesoid X receptor agonist
0,094  0,046  Transcription factor NF kappa B stimulant
0,075  0,027  MDM2 inhibitor
0,055  0,007  Cholesterol absorption inhibitor
0,058  0,011  GABA uptake inhibitor
0,135  0,088  Antidiabetic (type 1)
0,101  0,054  Lanosterol 14 alpha demethylase inhibitor
0,139  0,093  Pulmonary hypertension treatment
0,052  0,006  Integrin alpha1beta1 antagonist
0,071  0,025  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,056  0,011  Peroxisome proliferator-activated receptor delta agonist
0,060  0,015  Dopamine beta hydroxylase inhibitor
0,095  0,052  Restless leg syndrome treatment
0,059  0,017  Kainate receptor antagonist
0,078  0,037  Elastase 1 inhibitor
0,068  0,027  Ornithine carbamoyltransferase inhibitor
0,113  0,072  Anesthetic local
0,044  0,005  Prostaglandin H2 antagonist
0,092  0,053  Androgen antagonist
0,165  0,126  Antialcoholic
0,081  0,042  Lipase inhibitor
0,065  0,026  Ryanodine receptor antagonist
0,040  0,004  Retinoic acid beta receptor antagonist
0,039  0,003  Retinoid X beta receptor antagonist
0,069  0,034  Nitric oxide donor
0,040  0,005  Prostaglandin F2 alpha agonist
0,043  0,008  Glutamate (mGluR3) agonist
0,044  0,010  Prostaglandin D2 agonist
0,092  0,057  Glutamate release inhibitor
0,050  0,016  Membrane dipeptidase inhibitor
0,100  0,066  Antiviral (Poxvirus)
0,038  0,004  Integrin beta2 antagonist
0,129  0,095  Diuretic
0,052  0,019  Guanylate cyclase inhibitor
0,043  0,011  HMG CoA reductase inhibitor
0,116  0,084  Renal failure treatment
0,077  0,045  NMDA 2 receptor antagonist
0,071  0,039  Carbonic anhydrase inhibitor
0,075  0,043  Prostaglandin-E synthase inhibitor
0,044  0,013  Glutamate (mGluR4) agonist
0,047  0,017  Arginase inhibitor
0,039  0,009  NMDA receptor glycine site antagonist
0,094  0,064  Interleukin 12 antagonist
0,041  0,012  Lysophosphatidic acid 2 receptor antagonist
0,084  0,054  Antineoplastic antibiotic
0,033  0,004  Retinoic acid receptor gamma antagonist
0,033  0,005  GABA transporter inhibitor
0,045  0,018  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,041  0,014  Peroxisome proliferator-activated receptor delta antagonist
0,034  0,007  Integrin beta5 antagonist
0,106  0,079  Proteasome inhibitor
0,030  0,003  Glutamate (mGluR6) agonist
0,107  0,081  Beta amyloid protein antagonist
0,030  0,004  Vesicular glutamate transport inhibitor
0,107  0,082  Antiprotozoal (Babesia)
0,064  0,039  Caspase 9 inhibitor
0,029  0,004  Integrin alphaLbeta2 antagonist
0,039  0,015  HCV NS5B polymerase inhibitor
0,040  0,016  Estradiol 17 beta-dehydrogenase 3 inhibitor
0,043  0,019  Nicotinic acid receptor agonist
0,046  0,023  Liver X receptor alpha agonist
0,092  0,069  Sphingomyelinase inhibitor
0,067  0,043  Beta adrenoreceptor antagonist
0,056  0,033  Alpha-mannosidase inhibitor
0,049  0,026  NMDA receptor subunit 3B antagonist
0,052  0,029  Topoisomerase II beta inhibitor
0,065  0,043  Beta 3 adrenoreceptor antagonist
0,032  0,009  Kainate receptor 1 antagonist
0,115  0,093  Toll-Like receptor antagonist
0,033  0,011  Peroxisome proliferator-activated receptor alpha antagonist
0,079  0,058  Glycine receptor antagonist
0,186  0,165  Antimycobacterial
0,132  0,112  CF transmembrane conductance regulator agonist
0,042  0,022  5-Alpha-reductase inhibitor
0,057  0,038  Beta 1 adrenoreceptor antagonist
0,055  0,036  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,034  0,015  Uridine phosphorylase inhibitor
0,062  0,043  Beta 2 adrenoreceptor agonist
0,140  0,121  Lipocortins synthesis antagonist
0,054  0,036  Matrix metalloproteinase 1 inhibitor
0,029  0,011  Vanilloid 2 agonist
0,046  0,028  Dihydroorotase inhibitor
0,046  0,029  Integrin antagonist
0,041  0,024  Urate transporter 1 inhibitor
0,041  0,024  NMDA receptor subunit 3A antagonist
0,038  0,021  Glutamate (mGluR8) antagonist
0,030  0,013  Nicotinic acid receptor 2 antagonist
0,037  0,020  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,031  0,015  Kynurenine 3 monooxygenase inhibitor
0,021  0,005  Thromboxane A2 agonist
0,055  0,039  Carbonic anhydrase II inhibitor
0,040  0,025  CF transmembrane conductance regulator antagonist
0,167  0,152  Calpain inhibitor
0,026  0,011  Prostaglandin EP1 antagonist
0,035  0,021  Tubulin agonist
0,082  0,068  Interleukin 5 antagonist
0,100  0,087  Acetylcholine release stimulant
0,065  0,051  Sirtuin 1 inhibitor
0,017  0,004  Thyroid hormone beta agonist
0,025  0,012  Monocarboxylic acid transporter inhibitor
0,025  0,012  Monocarboxylic acid transporter 1 inhibitor
0,057  0,044  Sphingosine kinase inhibitor
0,050  0,037  Beta 2 adrenoreceptor antagonist
0,017  0,004  Thromboxane agonist
0,174  0,161  Amyotrophic lateral sclerosis treatment
0,037  0,025  Glutamate (mGluR3) antagonist
0,132  0,120  Interleukin 6 antagonist
0,028  0,015  Methionyl aminopeptidase 2 inhibitor
0,024  0,012  Isoleucine-tRNA ligase inhibitor
0,026  0,014  Prostaglandin D2 antagonist
0,044  0,033  Mannosidase inhibitor
0,018  0,006  GABA transporter 1 inhibitor
0,020  0,009  Prostacyclin agonist
0,062  0,051  Matrix metalloproteinase inhibitor
0,051  0,040  Ribonucleoside-diphosphate reductase inhibitor
0,029  0,018  Estrogen-related receptor gamma antagonist
0,052  0,041  Carbonic anhydrase IX inhibitor
0,137  0,127  Diabetic nephropathy treatment
0,148  0,138  Aryl hydrocarbon receptor agonist
0,129  0,119  Antianginal
0,033  0,023  Histone deacetylase 5 inhibitor
0,048  0,039  Prolyl endopeptidase inhibitor
0,045  0,035  Antimetabolite
0,051  0,042  Ribonucleotide reductase inhibitor
0,112  0,103  Antiprotozoal (Trichomonas)
0,066  0,057  Telomerase inhibitor
0,052  0,044  Sphingosine kinase 2 inhibitor
0,087  0,079  Antithrombocytopenic
0,033  0,025  Free fatty acid receptor 1 antagonist
0,040  0,032  Carbonic anhydrase IV inhibitor
0,020  0,013  5-Alpha-reductase 2 inhibitor
0,019  0,012  Estrogen-related receptor gamma agonist
0,063  0,056  HIV-1 reverse transcriptase inhibitor
0,017  0,011  Thyroid hormone alpha agonist
0,051  0,045  Sphingosine 1-phosphate receptor 5 agonist
0,123  0,118  Neuropathy treatment
0,062  0,056  Potassium channel large-conductance Ca-activated activator
0,113  0,108  Cytidine deaminase inhibitor
0,040  0,035  GABA B receptor antagonist
0,016  0,012  Vitamin D receptor agonist
0,045  0,042  Carbonic anhydrase XII inhibitor
0,041  0,037  AICAR transformylase inhibitor
0,053  0,050  Carbonic anhydrase stimulant
0,181  0,178  Thyroid hormone antagonist
0,163  0,160  Antiprotozoal (Trypanosoma)
0,021  0,019  Dopamine D1 agonist
0,013  0,010  1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor
0,023  0,021  Glutamate (mGluR1) agonist
0,006  0,004  Insulin like growth factor 3 antagonist
0,014  0,012  Thyroid hormone alpha antagonist
0,016  0,014  Telomerase stimulant
0,024  0,023  Urotensin II agonist
0,045  0,044  Antiviral (Herpesvirus 3, Human)
0,024  0,023  Lysine carboxypeptidase inhibitor
0,020  0,019  Glutamate (mGluR1a) agonist
0,037  0,037  VCAM-1 antagonist
0,077  0,076  Antiviral (Dengue virus)
0,019  0,019  Neuraminidase (Influenza B) inhibitor
0,037  0,037  VCAM antagonist
0,046  0,046  Anesthetic inhalation

